Chief Scientific Officer · Tyra Biosciences, Inc. (TYRA)

Ronald Swanson

A named executive officer of Tyra Biosciences in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,527,901

Salary $432,316Stock awards $0

FY2020: $487,024

2nd of 3 named executive officers at Tyra Biosciences by FY2021 total.

3 named officers on file for Tyra Biosciences, FY2021

Ronald Swanson’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Tyra Biosciences’s whole pay program stands against its peers

  • Tyra Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TYRA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A).

Free

Get Ronald Swanson’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Ronald Swanson compensation by year

Tyra Biosciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as Tyra Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$246,771$432,316
Bonus$0$0
Stock awards$0$0
Option awards$128,306$1,991,713
Non-equity incentive$111,047$102,951
Pension and deferred compensation$0$0
All other$900$921
Total$487,024$2,527,901

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Tyra Biosciences, Inc. DEF 14A filed April 28, 2022, accession 0001193125-22-127537, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Tyra Biosciences, Inc. filed document, accession 0001193125-22-127537. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

$487K
$2.5M
FY20
FY21
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU140,682$1,979,401—
Option7,964—$24.15
Option109,647—$2.25
Option7,964—$24.15
Option81,884—$24.15

Per the Outstanding Equity Awards at Fiscal Year-End table in Tyra Biosciences, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Tyra Biosciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Todd HarrisChief Executive Officer$6,377,563
Ronald Swanson · this pageChief Scientific Officer$2,527,901
Hiroomi TadaChief Medical Officer$2,511,361

The full Tyra Biosciences compensation record

free company brief

This page is one person within Tyra Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Tyra Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ronald Swanson's compensation dossier · One-time report. No refunds.